文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一例在达到诊断标准之前经组织学诊断的迟发性肝窦阻塞综合征病例。

A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria.

作者信息

Kuroha Takashi, Furukawa Tatsuo, Yoshikawa Seiichi, Kaihatsu Akane, Nemoto Hiroki, Usuda Hiroyuki, Yano Toshio

机构信息

Department of Hematology, Nagaoka Red Cross Hospital, 2-297-1, Senshu, Nagaoka, 940-2085, Japan.

Department of Gastroenterology, Nagaoka Red Cross Hospital, 2-297-1, Senshu, Nagaoka, 940-2085, Japan.

出版信息

Int J Hematol. 2025 Mar;121(3):421-426. doi: 10.1007/s12185-024-03909-7. Epub 2025 Jan 5.


DOI:10.1007/s12185-024-03909-7
PMID:39756003
Abstract

Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), is a life-threatening complication of hematopoietic stem cell transplantation. In severe cases, SOS/VOD progresses to multiple organ failure with a mortality rate higher than 80%. Early diagnosis and treatment based on severity assessment improve the prognosis of severe SOS/VOD, but conventional diagnostic criteria may be insufficient for an early diagnosis. We herein report a case of severe late-onset SOS/VOD that was histologically proven before clinical findings become evident. Although defibrotide therapy was started before the clinical diagnostic criteria were met, the disease progressed to multiple organ failure. This case suggests that some patients require earlier treatment before the appearance of clinical findings such as ascites and weight gain or hyperbilirubinemia, and supports the need to establish methods for predicting the onset and severity of SOS/VOD.

摘要

窦性阻塞综合征(SOS),也称为肝静脉闭塞病(VOD),是造血干细胞移植的一种危及生命的并发症。在严重情况下,SOS/VOD会进展为多器官功能衰竭,死亡率高于80%。基于严重程度评估的早期诊断和治疗可改善严重SOS/VOD的预后,但传统诊断标准可能不足以进行早期诊断。我们在此报告一例严重迟发性SOS/VOD病例,在临床症状明显之前经组织学证实。尽管在符合临床诊断标准之前就开始了去纤苷治疗,但疾病仍进展为多器官功能衰竭。该病例表明,一些患者在出现腹水、体重增加或高胆红素血症等临床症状之前需要更早的治疗,并支持建立预测SOS/VOD发病和严重程度方法的必要性。

相似文献

[1]
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria.

Int J Hematol. 2025-3

[2]
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.

Br J Haematol. 2017-7

[3]
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.

Biol Blood Marrow Transplant. 2017-6

[4]
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

Br J Haematol. 2013-9-17

[5]
Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.

Biol Blood Marrow Transplant. 2020-11

[6]
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.

Biol Blood Marrow Transplant. 2018-9-26

[7]
The use of defibrotide in blood and marrow transplantation.

Blood Adv. 2018-6-26

[8]
Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.

Expert Rev Gastroenterol Hepatol. 2017-9-4

[9]
[Diagnosis and treatment of sinusoidal obstruction syndrome (veno-occlusive disease)].

Rinsho Ketsueki. 2021

[10]
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.

Biol Blood Marrow Transplant. 2018-3-1

本文引用的文献

[1]
Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies development.

Front Immunol. 2022

[2]
Early diagnostic value of liver stiffness measurement in hepatic sinusoidal obstruction syndrome induced by hematopoietic stem cell transplantation.

World J Clin Cases. 2022-9-16

[3]
Imaging features of hepatic sinusoidal obstruction syndrome or veno-occlusive disease in children.

Pediatr Radiol. 2022-1

[4]
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.

Front Immunol. 2020

[5]
Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

Br J Haematol. 2020-9

[6]
HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide.

Int J Hematol. 2019-5-18

[7]
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.

Br J Haematol. 2018-5-16

[8]
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.

Br J Haematol. 2017-7

[9]
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.

Blood. 2016-3-31

[10]
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

Br J Haematol. 2013-9-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索